Abstract

BackgroundScale up of antiretroviral therapy (ART) has led to substantial declines in HIV related morbidity and mortality. However, attrition from ART care remains a major public health concern and has been identified as one of the key reportable indicators in assessing the success of ART programs. This study describes the incidence and predictors of attrition among adults initiating ART in a rural HIV clinic in Coastal Kenya.MethodsA retrospective cohort study design was used. Adults (≥15 years) initiated ART between January 2008 and December 2010 were followed up for two years. Attrition was defined as individuals who were either reported dead or lost to follow up (LFU, ≥ 180 days late since the last clinic visit). Kaplan Meier survival probabilities and Weibull baseline hazard regression analyses were used to model the incidence and predictors of time to attrition.ResultsOf the 928 eligible participants, 308 (33.2% [95% CI, 30.2 – 36.3]) underwent attrition at an incident rate of 23.1 (95% CI, 20.6 – 25.8)/100 pyo. Attrition at 6 and 12 months was 18.4% (95% CI, 16.0 – 21.1) and 23.2% (95% CI, 19.9 – 25.3) respectively. Gender (male vs. female, adjusted hazard ratio [95% CI], p-value: 1.5 [1.1 – 2.0], p = 0.014), age (15 – 24 vs. ≥ 45 years, 2.2 [1.3 – 3.7], p = 0.034) and baseline CD4 T-cell count (100 – 350 cells/uL vs. <100 cells/uL, 0.5 [0.3 – 0.7], p = 0.002) were independent predictors of time to attrition.ConclusionsA third of individuals initiating ART were either reported dead or LFU during two years of care, with more than a half of these occurring within six months of treatment initiation. Practical and sustainable biomedical interventions and psychosocial support systems are warranted to improve ART retention in this setting.

Highlights

  • Scale up of antiretroviral therapy (ART) has led to substantial declines in HIV related morbidity and mortality

  • Data from a rural HIV clinic in Coastal Kenya suggest that a third of adults who initiated ART were either LFU or reported dead after 2 years, with more than a half of the attrition occurring within six months of ART initiation

  • These findings indicate higher levels of attrition in this setting than suggested by data from systematic reviews of ART programs across sub-Saharan Africa (sSA) reporting around 25% attrition rates after 2 years [5,7]

Read more

Summary

Introduction

Scale up of antiretroviral therapy (ART) has led to substantial declines in HIV related morbidity and mortality. Attrition from ART care remains a major public health concern and has been identified as one of the key reportable indicators in assessing the success of ART programs. The number of HIV infected individuals receiving antiretroviral therapy (ART) in Africa rose from less than a million in 2005 to more than 7 million in 2012 [1], resulting to substantial declines in HIV related morbidity and mortality [2,3,4]. The World Health Organization (WHO) has identified retention (or attrition) as one of the key reportable indicators in assessing the success of ART programs [6]. The main components of attrition have been reported as loss to follow up (LFU, 56% to 59%) and death (around 40%) [5,7].

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call